Literature DB >> 22733232

Gastrointestinal cancer: a step closer to combating acquired resistance in CRC.

Lisa Hutchinson.   

Abstract

Entities:  

Year:  2012        PMID： 22733232     DOI： 10.1038/nrclinonc.2012.114

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  2 in total

1.  Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer.

Authors:  Sandra Misale; Rona Yaeger; Sebastijan Hobor; Elisa Scala; Manickam Janakiraman; David Liska; Emanuele Valtorta; Roberta Schiavo; Michela Buscarino; Giulia Siravegna; Katia Bencardino; Andrea Cercek; Chin-Tung Chen; Silvio Veronese; Carlo Zanon; Andrea Sartore-Bianchi; Marcello Gambacorta; Margherita Gallicchio; Efsevia Vakiani; Valentina Boscaro; Enzo Medico; Martin Weiser; Salvatore Siena; Federica Di Nicolantonio; David Solit; Alberto Bardelli
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962

2.  The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers.

Authors:  Luis A Diaz; Richard T Williams; Jian Wu; Isaac Kinde; J Randolph Hecht; Jordan Berlin; Benjamin Allen; Ivana Bozic; Johannes G Reiter; Martin A Nowak; Kenneth W Kinzler; Kelly S Oliner; Bert Vogelstein
Journal:  Nature       Date:  2012-06-28       Impact factor: 49.962
  2 in total
  2 in total

1.  Targeted therapies: the maths behind combination therapy.

Authors:  Rebecca Kirk
Journal:  Nat Rev Clin Oncol       Date:  2013-07-16       Impact factor: 66.675

Review 2.  Pharmacogenomics of Targeted Agents for Personalization of Colorectal Cancer Treatment.

Authors:  Alessia Bignucolo; Elena De Mattia; Erika Cecchin; Rossana Roncato; Giuseppe Toffoli
Journal:  Int J Mol Sci       Date:  2017-07-14       Impact factor: 5.923
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.